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Introduction: Antiphospholipid syndrome (APS) is characterized by recurrent arterial and venous thrombosis and
detection of antiphospholipid antibodies (aPLs). This syndrome may be associated with connective tissue disorders,
or with malignancies, but it may also appear in isolated form (primary APS). We report on a pediatric patient
presenting with acute adrenal failure as the first manifestation of primary APS.
Case report: A previously healthy 11-year-old boy developed fever, abdominal pain, and vomiting. An abdominal
computed tomography scan showed nodular lesions in the adrenal glands. He was referred to our Department and
a diagnosis of APS and acute adrenal failure was considered, based on positive aPLs (IgG and IgM), elevated ACTH
levels and low cortisol levels. Other features were anemia, thrombocytopenia, elevated inflammatory parameters,
hypergammaglobulinemia, prolonged partial thromboplastin time, positive antinuclear, anticardiolipin, anti-platelet
antibodies, with negative double-stranded DNA antibodies. Lupus anticoagulant and Coomb’s tests were positive.
MRI revealed a bilateral adrenal hemorrhage. A treatment with intravenous metylprednisolone, followed by oral
prednisone and anticoagulant, was started, resulting in a progressive improvement. After 2 months he also showed
hyponatremia and elevated renine levels, indicating a mineralcocorticoid deficiency, requiring fludrocortisones
therapy.
Conclusion: The development of acute adrenal failure from bilateral adrenal haemorrhage in the context of APS is
a rare but life-threatening event that should be promptly recognized and treated. Moreover, this case emphasizes
the importance of the assessment of aPLs in patients with acute adrenal failure in the context of an autoreaction.
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Primary adrenal insufficiency is a life-threatening event,
resulting from destruction or dysfunction of the adrenal
cortex. Signs and symptoms of adrenal insufficiency
appear when more than 90% of the cortex is destroyed
[1]. It is a rare disease with a prevalence in developed
countries of 90–140 per million, but it is thought to be
even less common in childhood [2]. Signs and symptoms
may be nonspecific and therefore the diagnosis is often
delayed, with risk of severe morbidity or mortality [3].
Recent data suggest that the most common causes of
acquired primary adrenal insufficiency are autoimmune
adrenalitis and tuberculosis, whereas only 5% of the cases
are related to unusual disorders [4].* Correspondence: salerno@unina.it
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reproduction in any medium, provided the orAdrenal insufficiency has been described in APS and is
thought to be the result of hemorrhage of adrenal
glands. APS is an autoimmune disorder characterized by
the persistent detection of antiphospholipid antibodies
(aPLs) and various clinical manifestations, the most com-
mon being venous and arterial thrombotic events, recur-
rent fetal loss, thrombocytopenia, livedo reticularis and
neurological manifestations. APS may occur in the con-
text of another autoimmune disease (secondary APS), or
may be a primary APS. In rare circumstances, APS is
defined as catastrophic due to an accelerated form of
multiorgan failure for an uncontrolled thrombosis [5].
Addison’s disease is reported in 0.4% of patients with
ascertained APS [6]. On the contrary, APS is diagnosed
in less than 0.5% of all patients with Addison’s disease
[7]. To date, there are only a few reports in the literaturel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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primary APS in pediatric patients.
Here we report on a 11-year-old boy with acute adrenal
failure, due to bilateral adrenal hemorrhage, as the pre-
senting feature of a primary APS.
Case report
A previously healthy 11-year-old boy developed persist-
ent fever, abdominal pain and vomiting. An abdominal
ultrasound echography was normal. An abdominal com-
puted tomography scan showed nodular lesions in the
adrenal glands. He was referred to our Department,
where the diagnosis of acute adrenal failure was made on
the basis of the clinical phenotype, mild hyponatremia
(132 mmol/l), high plasma ACTH level (961 pg/ml n.v.
10–130), low plasma cortisol levels (31,5 ng/ml n.v.
50–200), and normal aldosterone and renine levels.
MRI revealed a bilateral adrenal hemorrhage. Routine
analysis revealed anemia, thrombocytopenia, elevated in-
flammatory parameters, hypergammaglobulinemia and
prolonged partial thromboplastin time. A subclinical
hypothyroidism (SH) was diagnosed on the basis of mild
increase of TSH with normal levels of FT4 [8,9], in the
absence of thyroid autoantibodies. Subsequent diagnostic
work-up showed positive antinuclear, antiphospholipid
(IgG 20,9 IgM 27,3 n.v. <10), anticardiolipin antibodies
(56,6 U/ml n.v. 0–20), anti-platelet autoantibodies and
negative double-stranded DNA antibodies. Lupus anti-
coagulant and Coomb’s test were positive. A diagnosis of
antiphospholipid syndrome was performed.
Main causes of primary adrenal insufficiency were
ruled out. In particular, autoimmune Addison, a frequent
cause of acquired adrenal insufficiency also in the con-
text of APECED or others autoimmune syndromes
[10-13], was ruled out by clinical and biochemical
evaluation [14]. Family history was negative for APS or
any other autoimmune diseases.
A treatment with intravenous metylprednisolone, fol-
lowed by oral prednisone and anticoagulant, was promptly
started, resulting in a progressive improvement. TSH
levels spontaneously improved not requiring L-Thyroxine
therapy [15,16]. Two months later, mineralcorticoid defi-
ciency was diagnosed on the basis of hyponatremia, low
aldosterone and elevated renine levels (>300 pg/ml), re-
quiring fludrocortisone replacement therapy. The patient
is currently on cyclosporine therapy because of the recur-
rence of thrombocytopenia and positivity of lupus anti-
coagulant and Coomb’s tests, and antiphospholipid
antibodies. His general conditions are stable.
Discussion
Adrenal failure is a rare but potentially life-threatening
event. In childhood it generally presents with nonspecific
signs and symptoms, such as fatigue, malaise, abdominalpain, nausea and vomiting. Therefore, diagnosis and
treatment may be often delayed [3].
Main causes of congenital and acquired primary ad-
renal insufficiency are reported in Table 1 [17]. Adrenal
hemorrhage is a rare but well-known cause of adrenal
insufficiency. In a recent retrospective study on the pres-
entation of primary adrenal insufficiency in childhood,
adrenal haemorrhage was reported in only 2 of 77 cases
(3%) detected between 1999–2010 [3]. Adrenal glands
are highly susceptible to hemorrhagic damages [18].
The presence of antiphospholipid antibodies is a major
risk factor for hemorrhagic infarction of the adrenal
glands as a consequence of a thrombotic event [19]. The
detection of antiphospholipid antibodies in a subject
with thrombosis should lead to suspect a diagnosis of
APS. Criteria to confirm the diagnosis of APS include at
least one clinical sign, such as vascular thrombosis or
pregnancy complications, and one biochemical criterion
such as anticardiolipin IgG or IgM antibodies, lupus
anticoagulant of IgG or IgM classes detected in two
occasions at least 6–12 weeks a part [7,20]. Recent
evidence demonstrates that aPLs may recognize the
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thelial cells, whose activation switches them to a pro-
coagulant and pro-adhesive phenotype. Subsequently, the
great majority of clinical signs of APS, including adrenal
failure, are related to recurrent venous, arterial or small-
vessel thrombosis [21,22].
Besides vascular occlusion a great variety of non-
thrombotic manifestations may be associated [5,20].
Our patient had hematological complications, such as
hemolytic anemia and thrombocytopenia. The clinical
spectrum of antiphospholipid syndrome is very broad
and primary adrenal failure is considered a rare mani-
festation, particularly, in childhood.
Espinosa and colleagues reviewed all cases of primary
adrenal insufficiency associated with APS described in
the literature from 1983 (when APS was first defined)
through March 2002. Of the 86 patients identified,
6 (3 males) were less than 18 years old; 5 of these cases
had a primary APS and only one patient was diagnosed
with a SLE-like syndrome. Moreover, in two patients
Addison’s syndrome was the first manifestation of APS,
while in two children adrenal insufficiency developed in
the context of catastrophic APS. Furthermore, in two
cases precipitating factors were identified, such as neo-
natal infection and pneumonia [1].
In a recent study, Presotto et al. identified, throughout
a computer-assisted search of the literature from 1988
through January 2005, 19 cases of primary adrenal insuf-
ficiency as the heralding symptom of primary APS.
4 patients (2 males) were less than 18 years old and in
1 case a precipitating factor was identified [7]. Massive
bilateral adrenal hemorrhage has been also described in a
newborn with primary antiphospholipid syndrome
hypothesized basing on the persistent detection of antic-
ardiolipin antibodies after 6 months of life [18].
In our case, bilateral adrenal haemorrhage appeared to
be the first expression of a hypercoagulable state due to
the APS in the absence of any precipitating factor.
Of note, in our patient, the fact that the mineralcorti-
coid activity was damaged only later suggested a centrifu-
gal progression of adrenal impairment from the zona
reticularis to the zona glomerulosa, consistent with a
thrombosis of the central adrenal vein(s).Conclusion
In conclusion, the development of acute adrenal failure
due to bilateral adrenal haemorrhage in the context of
antiphospholipid syndrome is a rare but life-threatening
event that should be promptly recognized and treated.
Moreover, our case emphasizes the importance in the
assessment of antiphospholipid antibodies in all patients
with rapidly progressive acute adrenal failure in particular
when other autoimmune signs and symptoms are present.Consent
Written informed consent was obtained from the parents
of the patient for publication of this Case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
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